| Variable | Non-MOF group N = 1433 | MOF group N = 447 | value |
| Demographics and comorbidities | Median ages, years, mean (SD) | 51.14 (14.24) | 49.16 (14.05) | 0.826 | Male sex, N (%) | 869 (60.64) | 254 (56.82) | 0.151 | Hypertension, N (%) | 253 (17.66) | 102 (22.82) | 0.030 | Diabetes mellitus, N (%) | 203 (14.17) | 66 (14.77) | 0.916 | Apoplexy, N (%) | 81 (5.65) | 21 (4.70) | 0.109 | Hyperlipidemia, N (%) | 200 (13.96) | 67 (14.98) | 0.800 |
| Etiology | | | 0.002 | Biliary, N (%) | 595 (41.52) | 219 (49.00) | | Hypertriglyceridemia, N (%) | 633 (44.17) | 186 (41.61) | | Alcohol, N (%) | 91 (63.50) | 26 (5.82) | | Others, N (%) | 114 (7.96) | 16 (3.58) | |
| Outcomes | Surgery accepted, N (%) | 112 (7.82) | 99 (22.15) | <0.001 | Pancreatic necrosis, N (%) | 23 (1.61) | 379 (84.79) | <0.001 | ICU admission, N (%) | 8 (0.56) | 254 (56.82) | <0.001 | Median hospital days (IQR) | 9.00 (6.00–13.00) | 16.00 (10.00–27.00) | <0.001 | APACHE II score, mean (SD) | 4.22 (2.47) | 9.81 (5.36) | <0.001 | CCI, mean (SD) | 1.37 (0.88) | 2.30 (1.67) | <0.001 | Infection, N (%) | 2 (0.14) | 106 (23.71) | <0.001 | Mortality, N (%) | 0 (0) | 61 (13.65) | <0.001 | CRP, mg/L (IQR) | 0 (0.00–14.00) | 136 (0.00–219.00) | <0.001 | WBC, ×103/µL, mean (SD) | 14.78 ± 6.53 | 11.76 ± 5.65 | <0.001 | PCT, (IQR) | 0.00 (0.00–0.16) | 0.00 (0.00–0.55) | 0.287 | HCY, µmol/L (SD) | 12.78 (9.53) | 14.69 (10.59) | <0.001 | HCT, %, mean (SD) | 38.77 (9.32) | 39.60 (6.21) | <0.001 | BUN, mmol/L, mean (SD) | 5.09 (3.86) | 8.17 (7.02) | <0.001 | Creatinine, µmol/L, mean (SD) | 69.19 (58.69) | 107.59 (106.06) | <0.001 | TG, mmol/L, mean (SD) | 4.61 (7.82) | 4.59 (5.61) | 0.789 | HDL-C, mmol/L, mean (SD) | 0.96 (0.54) | 0.78 (0.55) | 0.254 | LDL-C, mmol/L, mean (SD) | 2.41 (1.71) | 2.44 (1.29) | 0.716 | LDH, U/L (IQR) | 226.60 (169.80–316.33) | 462.82 (285.90–743.05) | <0.001 | Glucose, mmol/L, mean (SD) | 7.90 (5.74) | 9.87 (4.69) | 0.014 | TC, mmol/L, mean (SD) | 5.53 (4.53) | 5.04 (4.47) | 0.086 | TBA, µmol/L (IQR) | 2.10 (0.80–5.30) | 2.80 (1.20–7.40) | 0.273 | Myoglobin, µg/L (IQR) | 44.30 (31.30–65.60) | 85.90 (48.60–225.05) | <0.001 | Creatine kinase, U/L (IQR) | 64.80 (41.40–108.10) | 123.05 (50.33–369.40) | <0.001 |
|
|